Year in Review: Multiple Myeloma
New drugs give physicians more options, but bad news for a prior accelerated approval
United States Mikkael Sekeres Philippe Moreau Mike Bassett University Hospital Oncologic Drugs Advisory Committee
Source: medpagetoday.com